![James Walter Glasheen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Walter Glasheen
Direktor/Vorstandsmitglied bei
ForSight VISION5, Inc.
Profil
James Walter Glasheen is currently a Director at ForSight VISION5, Inc., a Director at Epigenesis Pharmaceuticals LLC, a Managing Member at TP Management VII LLC, and a General Partner at Technology Partners.
He was previously an Independent Director at TRIA Beauty, Inc., a Director at Transcend Medical, Inc., an Independent Director at Soleno Therapeutics, Inc., an Independent Director at Revance Therapeutics, Inc., a Director at Incline Therapeutics, Inc., a Director at Elcelyx Therapeutics, Inc., a Director at Health360, Inc., a Managing Director at CIT Venture Capital, a Director at Leptos Biomedical, Inc., a Director at Essentialis, Inc., a Director at Medley Health, Inc., and a Member at McKinsey & Co., Inc. He received his undergraduate degree from Duke University and his graduate and doctorate degrees from Harvard University.
Aktive Positionen von James Walter Glasheen
| Unternehmen | Position | Beginn |
|---|---|---|
Technology Partners
 Technology Partners Investment ManagersFinance Technology Partners invests in companies located in the United States. The firm targets companies operating in the fields of cleantech and life science sectors. It provides financing for seed, early and later stage capital requirements. | Private Equity Investor | 01.01.2002 |
Epigenesis Pharmaceuticals LLC
 Epigenesis Pharmaceuticals LLC Pharmaceuticals: OtherHealth Technology Develops inhaled respiratory medicines | Direktor/Vorstandsmitglied | - |
ForSight VISION5, Inc.
 ForSight VISION5, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops ocular drug delivery technologies and device solutions for ophthalmic diseases | Direktor/Vorstandsmitglied | - |
TP Management VII LLC
 TP Management VII LLC Investment Trusts/Mutual FundsMiscellaneous Part of Technology Partners, TP Management VII LLC is a company based in Palo Alto, CA. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von James Walter Glasheen
| Unternehmen | Position | Ende |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 16.10.2018 |
| REVANCE THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.07.2016 |
Health360, Inc.
 Health360, Inc. Medical/Nursing ServicesHealth Services Provides health services | Direktor/Vorstandsmitglied | 30.01.2013 |
Leptos Biomedical, Inc.
 Leptos Biomedical, Inc. Medical SpecialtiesHealth Technology Provides medical services for chronic obesity patients | Direktor/Vorstandsmitglied | 12.11.2010 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | - |
Ausbildung von James Walter Glasheen
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
98
Beziehungen ersten Grades
18
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 18 |
|---|---|
TRIA Beauty, Inc.
 TRIA Beauty, Inc. Medical SpecialtiesHealth Technology Manufactures and retails hair removal and skincare devices through online | Health Technology |
Transcend Medical, Inc.
 Transcend Medical, Inc. Medical SpecialtiesHealth Technology Operates as a medical device company | Health Technology |
TP Management VII LLC
TP Management VII LLC Investment Trusts/Mutual FundsMiscellaneous Part of Technology Partners, TP Management VII LLC is a company based in Palo Alto, CA. | Miscellaneous |
Soleno Therapeutics, Inc.
 Soleno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapeutics for the treatment of rare diseases | Health Technology |
Revance Therapeutics, Inc.
 Revance Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for esthetics, skincare and therapeutics | Health Technology |
Incline Therapeutics, Inc.
 Incline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Elcelyx Therapeutics, Inc.
 Elcelyx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics based on gut sensory modulation | Health Technology |
Health360, Inc.
Health360, Inc. Medical/Nursing ServicesHealth Services Provides health services | Health Services |
ForSight VISION5, Inc.
ForSight VISION5, Inc. Electronic Equipment/InstrumentsElectronic Technology Develops ocular drug delivery technologies and device solutions for ophthalmic diseases | Electronic Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Technology Partners
Technology Partners Investment ManagersFinance Technology Partners invests in companies located in the United States. The firm targets companies operating in the fields of cleantech and life science sectors. It provides financing for seed, early and later stage capital requirements. | Finance |
Epigenesis Pharmaceuticals LLC
Epigenesis Pharmaceuticals LLC Pharmaceuticals: OtherHealth Technology Develops inhaled respiratory medicines | Health Technology |
CIT Venture Capital
 CIT Venture Capital Investment ManagersFinance CIT Venture Capital specializes in LBOs, MBOs, recapitalizations, growth financings and venture capital investments in the life science, telecommunications and technology sectors. Within the telecommunications and technology sectors, the firm seeks to invest in the following industries: communications services, wireless technologies, communications equipment, software and Internet-enabling technologies. Their life sciences investments focus on biopharmaceuticals, medical devices and pharmaceutical services. CIT Venture Capital prefers to invest in companies based in the US. For buyouts, the firm seeks to invest in transactions valued at more than $50 million, contributing at least $7.5 million in equity per transaction. For growth financings, they target companies with annual sales greater that $50 million and will contribute a minimum of $4 million in equity. For technology, communications and life sciences venture capital transactions, CIT Venture Capital invests $2 million to $15 million in equity per transaction. Their investment horizon is typically 3 to 7 years. CIT Venture Capital prefers to take majority stakes in their portfolio companies, but also considers significant minority stakes | Finance |
Leptos Biomedical, Inc.
Leptos Biomedical, Inc. Medical SpecialtiesHealth Technology Provides medical services for chronic obesity patients | Health Technology |
Essentialis, Inc.
 Essentialis, Inc. Pharmaceuticals: OtherHealth Technology Develops therapeutic products in curing metabolic diseases | Health Technology |
Medley Health, Inc.
 Medley Health, Inc. Miscellaneous Commercial ServicesCommercial Services Provides marketing and communications services | Commercial Services |
